Etiological and prognostic aspects of renal failure in patients with prostatic adenoma


Cite item

Full Text

Abstract

The aim of our study was to assess the causes of renal failure in patients with prostatic adenoma (PA) and outcomes after draining of the urinary bladder. A retrospective study comprised 239 PA patients with a serum creatinine level over 120 mcmol/l. Outcomes were assessed after 3-5 day and 2.5 month bladder draining. The Spearman test was used for statistical analysis. We found that age, prostate volume, PA growth pattern, urinary tract infection, concomitant pathology (arterial hypertension, diabetes mellitus, atherosclerosis) do not correlate with a serum creatinine level. The presence of bilateral retention of the upper urinary tract was associated with a higher serum creatinine level. There is a significant correlation between lowering of a serum creatinine concentration after bladder draining and the level of upper urinary tract retention.

References

  1. Levey A. S., Coresh J., Balk E. et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann. Intern. Med. 2003; 139: 137-147.
  2. Emberton M., Andriole G. L., de la Rosette J. et al. Benign prostatic hyperplalsia: A progressive disease of aging men. Urology 2003; 61: 267-273.
  3. Haroun M. K., Bernard G. J., Hoffman S. C. et al. Risk factors for chronic kidney disease: A prospective study of 23534 men and women in Washington County, Maryland. J. Am. Soc. Nephrol. 2003; 14: 2934-2941.
  4. Fox C. S., Larson M. G., Leip E. P. et al. Predictors of new-onset kidney disease in a community-based population. J. A. M. A. 2004; 291: 844-850.
  5. Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in US adults. Ann. Intern. Med. 2004; 140: 167-174.
  6. Rohrmann S., Smit E., Giovannucci E. et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int. J. Obesity 2005; 29: 310- 316.
  7. Benign prostatic hyperplasia diagnosis and treatment. Clinical practice guideline, Number 8 Agency for Health Care Policy and Research Publication / McConnell J. D., Barry M. J., Bruskewitz R. L. et al. Rockwille: Maryland: Public Health Service, United States Department of Health and Human Services; 1994. 225.
  8. Hunter D. J., Berra-Unamuno A., Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J. Urol. (Baltimore) 1996; 155: 1965-1969.
  9. Hill A. M., Philpott N., Kay J. D. et al. Prevalence and outcome of renal impairment at prostatectomy. Br. J. Urol. 1993; 71: 464-471.
  10. Gerber G. S., Goldfisher E. R., Karrison T. G. et al. Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 1997; 49: 697-702.
  11. McConnel J. D., Roehrborn C. G., Bautista D. M. et al. The long-term effect of doxasosin, finasteride and combination therapy on the clinical progression of benign prostatic hyperplasia. N. Engl. J. Med. 2003; 18: 2387-2399.
  12. Mukamel E., Nissenkorn I., Boner G. et al. Occult progressive renal damage in the elderly male due to benign prostatic hypertrophy. J. Am. Geriatr. Soc. 1979; 27: 403-408.
  13. Olbrich O., Woodford-Williams E., Irvine R. E., Webster D. Renal function in prostatism. Lancet 1957; 1: 1322-1326.
  14. Terris M. K., Afzal N., Kabalin J. N. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate and post-void residual volume. Urology 1998; 52: 462-468.
  15. Rule A., Jacobsen D. J., Roberts R. O. et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005; 67: 2376-2382.
  16. Styles R. A., Neal D. E., Griffiths C. J. et al. Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and upper tract dilatation. J. Urol. (Baltimore) 1998; 140: 330-335.
  17. Comiter C. V., Sullivan M. P., Schacterle R. S. et al. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. J. Urol. (Baltimore) 1997; 158: 181-187.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies